Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

3 Reasons to Buy High-Yield Enbridge Stock Like There's No Tomorrowfool.com
Enbridge is a Canadian midstream giant, but it comes with an interesting twist.
Via The Motley Fool · December 24, 2025
Rivian Stock Popped 15% Thursday, but There Could Be Room to Runfool.com
Rivian received a vote of confidence and a boost in stock price recently. Here's why there could be more room to run.
Via The Motley Fool · December 24, 2025
Building an Emergency Fund on a Modest Income
Unexpected expenses do not care how tight your budget is. A flat tire, a lost shift at work, a sick pet, a higher heating bill in winter — any of these can throw off your month if every dollar already has a job. An emergency fund is simply a small pile of money that keeps [...]
Via Visibility · December 23, 2025
Crocs: A Surprising Investment Opportunity in the Footwear Marketfool.com
Could Crocs be more than just a fad? Join us as we evaluate the company's strengths and weaknesses, and discover if this stock is a hidden gem waiting to be uncovered.
Via The Motley Fool · December 24, 2025
Camtek Hits Record Revenue but Here's Why One Fund Still Cut $3 Million Amid a 30% Runfool.com
Camtek just printed its strongest quarter ever, but one investor quietly took chips off the table, and the timing says a lot about how professionals think after big semiconductor rallies.
Via The Motley Fool · December 24, 2025
Huntsman Stock Is Down 45% This Past Year, but One Fund Is Doubling Down With a $10 Million Betfool.com
With Huntsman trading near multi-year lows, one manager appears to be betting that cash flow and restructuring matter more than near-term earnings pain.
Via The Motley Fool · December 24, 2025
Why Travere Therapeutics Stock Popped by Nearly 14% on Wednesdayfool.com
Two analysts waxed bullish on the future of the company.
Via The Motley Fool · December 24, 2025
Should You Buy Ares Capital (ARCC) Stock Before February?fool.com
This high-yielding stock faces some near-term challenges.
Via The Motley Fool · December 24, 2025
Why a Fund Slashed Its Chord Energy Stake by 80% as the Stock Sits 50% Below Its Peakfool.com
With energy prices swinging and capital discipline under pressure, one manager is quietly dialing back risk in a stock that has punished even patient holders.
Via The Motley Fool · December 24, 2025
Trump Dishes On Santa's Cookie Cravings During Call With Kids: 'He Tends To Be A Little On The Cherubic Side'benzinga.com
Ex-president Donald Trump and first lady Melania took part in NORAD's Santa Tracker hotline, fielding calls and joking about cookies and coal.
Via Benzinga · December 24, 2025
Is MannKind Stock a Buy or Sell After the CEO Sold Nearly 66,000 Shares?fool.com
This biotech innovator in inhaled therapeutics reported a notable insider sale amid ongoing product development and licensing activity.
Via The Motley Fool · December 24, 2025
Why One Florida Fund Opened a $4 Million Bet on California Resources Despite a 15% Stock Slidefool.com
With cash piling up, debt rolling off, and shareholder returns accelerating, one small fund is stepping into a battered energy name at a moment when the fundamentals look steadier than the stock.
Via The Motley Fool · December 24, 2025
What to Consider Before Adding This Emerging Markets ETF to Your Portfoliofool.com
Emerging market equities bounced back in a big way in 2025, highlighting the advantages of this cheap-to-own Vanguard ETF.
Via The Motley Fool · December 24, 2025
Will Quantum Computing Inc. (QUBT) Stock Keep Its Losing Streak Going in 2026?fool.com
The company has promising technology, but will it be commercially viable?
Via The Motley Fool · December 24, 2025
Why Edgewise Therapeutics Stock Rocked the Market Todayfool.com
The company just might have a winner on its hands with a pipeline heart disease treatment.
Via The Motley Fool · December 24, 2025
'Just Go Union'? Electrician Applied At Every Company In His City And Says The Blue-Collar Apprentice Pipeline Is Worn Out, Backlogged, and Gatekeptbenzinga.com
Via Benzinga · December 24, 2025
Charted: Countries Stockpiling The Most Gold Reserves Since 2000content/com
Since the turn of the century, central banks have been steadily increasing their gold reserves, a trend that has sharply accelerated in the last few years.
Via Talk Markets · December 24, 2025
Forget MP Materials: This Rare Earth Stock Is Up 21% in 2025 With More Upside Aheadfool.com
USA Rare Earth could be shaping up for a game-changing year in 2026.
Via The Motley Fool · December 24, 2025
Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Foreverfool.com
If you are looking for high yields, this drug maker and this device maker are both worth a deep dive today.
Via The Motley Fool · December 24, 2025
Ranking the Best "Magnificent Seven" Stocks to Buy for 2026. Here's My No. 4fool.com
This company is expected to deliver solid, yet unspectacular, growth in 2026.
Via The Motley Fool · December 24, 2025
Why Omeros Stock Skyrocketed Todayfool.com
The company is on the brink of commercializing a unique medication.
Via The Motley Fool · December 24, 2025
Debt Distress, Metal Mayhemcontent/com
The two things that typically feature in an empire’s last chapters are excess spending...and unnecessary war. Both are self-inflicted wounds that fester…and eventually kill the host.
Via Talk Markets · December 24, 2025
Prescription for Growth: Why Zoetis and Viatris are Defining Healthcare’s New Winners in 2025
As the curtain closes on 2025, the healthcare sector has emerged as a landscape of stark contrasts. While traditional pharmaceutical giants have grappled with the implementation of the Medicare Part D out-of-pocket caps and shifting regulatory winds, two specific "growth pockets"—animal health and specialty/complex generics—have captured investor
Via MarketMinute · December 24, 2025
Building Through the Storm: How PulteGroup and the Housing Sector Defied the Odds in 2025
As the sun sets on 2025, the U.S. housing market stands at a fascinating crossroads. For much of the year, investors and homebuyers alike were held captive by the Federal Reserve's "higher-for-longer" interest rate narrative. Yet, against a backdrop of mortgage rates that stubbornly refused to retreat to the
Via MarketMinute · December 24, 2025
Defensive Giants: Why Residential and Healthcare REITs are Dominating the 2025 Market Landscape
As 2025 draws to a close, a striking divergence has emerged in the equity markets. While the broader indices have grappled with the "tug-of-war" between Federal Reserve policy shifts and persistent inflationary pressures, the Real Estate Investment Trust (REIT) sector has found a second wind. Specifically, residential and healthcare REITs
Via MarketMinute · December 24, 2025